Role of p16/INK4a in gastrointestinal stromal tumor progression

American Journal of Clinical Pathology

Volumn 122, Issue 1, 2004, Pages 35-43

  Ricci, Riccardo ^a   Arena, Vincenzo ^a   Castri, Federica ^a   Martini, Maurizio ^a   Maggiano, Nicola ^a   Murazio, Marino ^a   Pacelli, Fabio ^a   Potenza, Angelo E ^a   Vecchio, Fabio M ^a   Larocca, Luigi M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Gastrointestinal stromal tumor; P16; Tumor prognostication; Tumor progression

Indexed keywords

CD34 ANTIGEN; COMPLEMENTARY DNA; CYCLIN D; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; MESSENGER RNA; PROTEIN P16; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR LOCALIZATION;

EID: 3042723785     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/MJ4XN2M57HNC8X5H     Document Type: Article

References (24)

1. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459-465.
2. Berman J, O'Leary TJ. Gastrointestinal stromal tumor workshop. Hum Pathol. 2001;32:578-582.
3. Dematteo RP, Heinrich MC, El-Rifai WM, et al. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol. 2002;33:466-477.
4. Debiec-Rychter M, Lasota J, Sarlomo-Rikala M, et al. Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation. Cancer Genet Cytogenet. 2001;128:24-30.
5. El-Rifai W, Sarlomo-Rikala M, Andersson LC, et al. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res. 2000;60:3899-3903.
6. Kim NG, Kim JJ, Ahn JY, et al. Putative chromosomal deletions on 9p, 9q and 22q occur preferentially in malignant gastrointestinal stromal tumors. Int J Cancer. 2000;85:633-638.
7. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta. 2002;1602:73-87.
8. Cohen JA, Geradts J. Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas. Hum Pathol. 1997;28:893-898.
9. Dei Tos AP, Maestro R, Doglioni C, et al. Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol. 1996;148:1037-1045.
10. Iolascon A, Faienza MF, Coppola B, et al. Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma. Genes Chromosomes Cancer. 1996;15:217-222.
11. Serrano M, Lee H, Chin L, et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996;85:27-37.
12. Schneider-Stock R, Boltze C, Lasota J, et al. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol. 2003;21:1688-1697.
13. Bastian D, Ramaswamy A, Barth PJ, et al. Malignant fibrous histiocytoma of the pancreas: a case report with genetic analysis. Cancer. 1999;85:2352-2358.
14. Yoo J, Park SY, Kang SJ, et al. Altered expression of G1 regulatory proteins in human soft tissue sarcomas. Arch Pathol Lab Med. 2002;126:567-573.
15. Teofili L, Martini M, Di Mario A, et al. Expression of p15(ink4b) gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitors. Blood. 2001;98:495-497.
16. Teofili L, Morosetti R, Martini M, et al. Expression of cyclin-dependent kinase inhibitor p15(INK4B) during normal and leukemic myeloid differentiation. Exp Hematol. 2000;28:519-526.
17. Martini M, Ciccarone M, Garganese G, et al. Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis. Int J Cancer. 2002;102:398-406.
18. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;93:9821-9826.
19. Meye A, Wurl P, Hinze R, et al. No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas. J Pathol. 1998;184:14-17.
20. Maitra A, Roberts H, Weinberg AG, et al. Aberrant expression of tumor suppressor proteins in the Ewing family of tumors. Arch Pathol Lab Med. 2001;125:1207-1212.
21. Hui AM, Sakamoto M, Kanai Y, et al. Inactivation of p16INK4 in hepatocellular carcinoma. Hepatology. 1996;24:575-579.
22. Heinrich MC, Rubin BP, Longley BJ, et al. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol. 2002;33:484-495.
23. Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001;61:8118-8121.
24. Feng LX, Ravindranath N, Dym M. Stem cell factor/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia. J Biol Chem. 2000;275:25572-25576.